The nation of Zimbabwe has turned down a significant US health deal valued at 367 million US dollars (272 million pounds) over five years over Washington's insistence on confidential information.
This rejection came to light after a government memo from December was disclosed, which showed President Emmerson Mnangagwa felt the deal was "unbalanced".
A government representative later explained that the United States was seeking genetic material for research and commercial gain but was unwilling to guarantee the benefits from any future treatments.
"We are forced to start the difficult and regrettable task of winding down our health assistance in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy noted the United States had provided over $1.9bn as health assistance to Zimbabwe during the past two decades.
A physicians' group in Zimbabwe has called for more talks to reach a deal agreeable to all parties so the country's vital HIV programme can continue.
Wider Background
This development follows a comparable case in neighbouring Kenya, where a high court blocked a similar health funding agreement following concerns were filed about the security of Kenyans' health data.
After resuming office last year, US President Donald Trump has drastically cut overseas assistance and shut down the key foreign aid agency.
The agency had overseen aid for the US government, but Trump stated its expenditure was "wasteful" and his government was pursuing government-to-government agreements to boost openness and responsibility.
As per statements, Sixteen African countries have so far agreed to these new agreements, representing over $18.3bn of fresh investment.
Details of the Rejected Agreement
The funds for Zimbabwe was intended to funded "combating HIV/Aids, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We believe this partnership could have provided significant advantages for the people of Zimbabwe, especially the 1.2 million men, women and children currently receiving HIV treatment via US-supported initiatives," Tremont added.
However, official spokesman Nick Mangwana argued the proposed deal was "asymmetrical".
"Zimbabwe was being asked to surrender its biological resources and data over an extended period, with no corresponding guarantee of access to any medical innovations – like new medicines or tests – that might be developed from that provided information," he stated.
"Effectively, our country would supply the raw materials for scientific discovery with no assurance that the end products would be accessible to our population if a new disease outbreak emerge."
Sovereignty and International Frameworks
He also said that the US's withdrawal from the World Health Organization (WHO) and its push of one-on-one deals were undermining frameworks already set up through the global organization.
The spokesperson cited its Pandemic Benefit-Sharing scheme created to manage potential global health emergencies.
"This mechanism is intended to guarantee that when a nation provides its data, the benefits – such as medicines and cures – are distributed fairly, not monopolised exclusively by those with the resources to create them."
These objections over the US deal "must not be interpreted as anti-American sentiment," he added.
"We encourage ongoing dialogue with our American counterparts on how subsequent collaboration might be arranged in a manner that honours the sovereignty and interests of each country."
Health Experts Response
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it recognised the government's concerns, but urged that talks should continue considering a large portion of the nation's HIV programmes relied on international support.
"In cases where technical issues arise, including those relating to data governance or agreement terms, these can often be addressed via detailed discussion and negotiated safeguards," it added.
This impasse emphasises the complex debate between accepting much-needed international aid and safeguarding a country's data in an ever more interconnected world.